97 related articles for article (PubMed ID: 437911)
21. Circulating immune complexes in patients with hematologic diseases.
Yen JH; Liu HW; Lin SF; Chen TP; Chang CS; Liu TC; Tsai WJ
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1989 May; 22(2):138-44. PubMed ID: 2605974
[TBL] [Abstract][Full Text] [Related]
22. A comparison of two 125I C1q binding tests to detect soluble immune complexes in serum of patients with malignant disease.
Shepherd PS
Clin Exp Immunol; 1979 May; 36(2):250-5. PubMed ID: 477028
[TBL] [Abstract][Full Text] [Related]
23. Relevance of circulating immune complexes in childhood acute lymphoblastic leukaemia.
Clague RB; Kumar S; Hann IM; Jones PH; Holt PJ
Int J Cancer; 1978 Sep; 22(3):227-30. PubMed ID: 279522
[TBL] [Abstract][Full Text] [Related]
24. Delay in progression of malignant lymphoma after BCG vaccination.
Sokal JE; Aungst CW; Snyderman M
N Engl J Med; 1974 Dec; 291(23):1226-30. PubMed ID: 4609380
[No Abstract] [Full Text] [Related]
25. Effects of radiochemotherapy and splenectomy on cellular immunity in long-term survivors of Hodgkin's disease and non-Hodgkin's lymphoma.
Steele R; Han T
Cancer; 1978 Jul; 42(1):133-9. PubMed ID: 667791
[TBL] [Abstract][Full Text] [Related]
26. Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation.
Becherer A; Mitterbauer M; Jaeger U; Kalhs P; Greinix HT; Karanikas G; Pötzi C; Raderer M; Dudczak R; Kletter K
Leukemia; 2002 Feb; 16(2):260-7. PubMed ID: 11840293
[TBL] [Abstract][Full Text] [Related]
27. Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?
Josting A; Reiser M; Rueffer U; Salzberger B; Diehl V; Engert A
J Clin Oncol; 2000 Jan; 18(2):332-9. PubMed ID: 10637247
[TBL] [Abstract][Full Text] [Related]
28. [Activation of the immune system and remission period in malignant lymphomas].
Havemann K; Schultz H
Hamatol Bluttransfus; 1976; 18():329-38. PubMed ID: 964711
[No Abstract] [Full Text] [Related]
29. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
[TBL] [Abstract][Full Text] [Related]
30. Survey of human polyomavirus (JCV, BKV) infections in 139 patients with lung cancer, breast cancer, melanoma, or lymphoma.
Hogan TF; Padgett BL; Walker DL; Borden EC; Frias Z
Prog Clin Biol Res; 1983; 105():311-24. PubMed ID: 6304768
[TBL] [Abstract][Full Text] [Related]
31. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
Urquhart A; Berg R
Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
[TBL] [Abstract][Full Text] [Related]
32. Hodgkin's and non-Hodgkin's lymphomas.
McElwain TJ
Br J Hosp Med; 1984 Jan; 31(1):10-4, 18-9. PubMed ID: 6697038
[No Abstract] [Full Text] [Related]
33. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
[TBL] [Abstract][Full Text] [Related]
34. [When to terminate the treatment of children with Hodgkin's disease, lymphoblastic leukemia and non-Hodgkin's lymphoma. Analysis of 80 cases].
Armata J
Pediatr Pol; 1979 Aug; 54(8):877-85. PubMed ID: 291888
[No Abstract] [Full Text] [Related]
35. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
[TBL] [Abstract][Full Text] [Related]
36. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors.
Caballero MD; Rubio V; Rifon J; Heras I; García-Sanz R; Vázquez L; Vidriales B; del Cañizo MC; Corral M; Gonzalez M; León A; Jean-Paul E; Rocha E; Moraleda JM; San Miguel JF
Bone Marrow Transplant; 1997 Sep; 20(6):451-8. PubMed ID: 9313877
[TBL] [Abstract][Full Text] [Related]
37. Correlation between immune complexes and prognostic factors in Hodgkin's disease.
Amlot PL; Pussell B; Slaney JM; Williams BD
Clin Exp Immunol; 1978 Feb; 31(2):166-73. PubMed ID: 648026
[TBL] [Abstract][Full Text] [Related]
38. Characterization and expression of CT45 in Hodgkin's lymphoma.
Heidebrecht HJ; Claviez A; Kruse ML; Pollmann M; Buck F; Harder S; Tiemann M; Dörffel W; Parwaresch R
Clin Cancer Res; 2006 Aug; 12(16):4804-11. PubMed ID: 16914565
[TBL] [Abstract][Full Text] [Related]
39. Characterization of immune complexes in acute lymphoblastic leukaemia.
Williams RC; Duncan MH; Tung KS; Stinson ER; Walker LC; Greaves MF
Clin Exp Immunol; 1983 Nov; 54(2):418-28. PubMed ID: 6606508
[TBL] [Abstract][Full Text] [Related]
40. Circulating immune complexes in acute leukemia.
Cermák J; Feyereislová A; Horejsí J
Neoplasma; 1989; 36(1):21-7. PubMed ID: 2704422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
